Neurocrine Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2024
Total Assets: $3.72B
Liabilities Breakdown FY2024
Total Liabilities: $1.13B
Asset Breakdown
Total Assets: $3.72B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $233.0M | 6.3% |
| Accounts Receivable | $479.1M | 12.9% |
| Inventory | $57.4M | 1.5% |
| Property, Plant & Equipment | $82.6M | 2.2% |
| Goodwill | $5.7M | 0.2% |
| Intangible Assets | $36.5M | 1.0% |
| Other Assets | $2.82B | 76.0% |
Liabilities Breakdown
Total Liabilities: $1.13B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $461.6M | 40.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $667.4M | 59.1% |